Amgen USA Inc.
Thousand Oaks, CA Amgen USA Part of Amgen Inc.
- UEI
- XPGNQMXHP493
- CAGE
- 5YNZ4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Amgen Inc.
Parent
D92HARF1LKA9
- Amgen USA Inc. XPGNQMXHP493
-
Amgen Inc.
Parent
D92HARF1LKA9
- SAM.gov registration date
- Physical address
- 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA
- Website
- amgen.com
- Founded
- 1980
- Employees
- 10K-50K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Vendor managed inventory (VMI) services for USG procured 165,906 doses of neulasta product to mitigate injuries caused… | Office of the Assistant Secretary for Preparedness and Response | $811,924 | |
| Tavneos (avacopan) | Veterans Integrated Service Network 20 | $65,210 | |
| Treatment for use in a mass casualty event where thrombocytopenia or platelet loss is a major concern. | Office of the Assistant Secretary for Preparedness and Response | $839,875,190 | |
| Afluria quadrivalent 0.5ML single-dose, pre-filled quadrivalent syringes designated for persons 36 months and older… | Veterans Integrated Service Network 5 | $74,669 | |
| To provide flu shots for FY 2021 for staff at the federal correctional institution terminal island, CA. | Federal Correctional Institution Terminal Island | $2,575 |
About Amgen USA Inc.
Amgen USA Inc., Amgen USA Division, is a registered federal contractor providing pharmaceutical products and services to various government agencies. As a division of Amgen Inc., a leading biotechnology company, Amgen USA specializes in developing innovative therapies for serious illnesses. The company has been actively engaged in federal contracting since its registration in SAM.gov on April 2, 2010, with its current registration valid until April 2, 2025. Amgen USA is structured as a for-profit corporate entity and is classified as a manufacturer of goods.
Amgen USA has secured several significant federal contract awards in recent years, primarily in the healthcare and pharmaceutical sectors. A major contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response involves the provision of vendor managed inventory services for 165,906 doses of Neulasta, a drug used to mitigate injuries from chemical, biological, radiological, nuclear, and physical threats. Another substantial award from the same agency, valued at over $1 billion, is for the delivery of an FDA-approved thrombopoietin receptor agonist to treat thrombocytopenia resulting from acute radiation syndrome. The company has also received contracts from the Department of Veterans Affairs for supplying pharmaceuticals such as TAVNEOS (AVACOPAN) and influenza vaccines. Additionally, Amgen USA has provided flu shots to staff at federal correctional facilities under contracts with the Department of Justice Bureau of Prisons.
Amgen USA holds two significant federal contract IDVs. The first is a Federal Supply Schedule contract (36F79721D0086) awarded by the Department of Veterans Affairs, with a ceiling value of $3.37 billion. This multiple-award vehicle, under the GSA Pharmaceuticals and Drugs (FSS-61-IB) schedule, allows Amgen to supply pharmaceuticals, drugs, and hematology-related products to various federal agencies. The second IDV (36E79720D0006) is a single-award indefinite delivery contract from the VA National Acquisition Center, with a ceiling value of $58.97 million. This contract focuses on supplying calcitonin gene-related peptide agents to the VA, Bureau of Prisons, and Indian Health Service. Under these IDVs, Amgen has received task orders for products such as TAVNEOS and influenza vaccines, demonstrating the company's role in providing critical medical supplies to support federal healthcare initiatives.
Contract vehicles
Quick answers
What is Amgen USA Inc.'s UEI?
Amgen USA Inc.'s Unique Entity ID (UEI) in SAM.gov is XPGNQMXHP493.
What is Amgen USA Inc.'s CAGE code?
Amgen USA Inc.'s CAGE code is 5YNZ4.
What is Amgen USA Inc.'s primary NAICS code?
Amgen USA Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Amgen USA Inc. located?
Amgen USA Inc.'s physical address in SAM.gov is 1 Amgen Center Dr, Thousand Oaks, CA 91320, USA.
Is Amgen USA Inc. registered in SAM.gov?
Yes. Amgen USA Inc.'s SAM.gov registration is active through March 19, 2027.
Who is Amgen USA Inc.'s parent company?
Amgen USA Inc. is part of Amgen Inc.
Which contract vehicles does Amgen USA Inc. hold?
Amgen USA Inc. holds a place on 2 federal contract vehicles, including FSS-61-IB.
What is Amgen USA Inc.'s most recent federal award?
Amgen USA Inc.'s most recent federal contract award is Vendor managed inventory (VMI) services for USG procured 165,906 doses of neulasta product to mitigate injuries caused… (75A50124C00011), from Office of the Assistant Secretary for Preparedness and Response, on March 12, 2024.
On GovTribe
See Amgen USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors